Human Reproduction, Vol. 8, No. 1, pp. 119-121, 1993
© 1993 European Society of Human Reproduction and Embryology
other |
Changes in adrenergic receptors in the pregnant human uterine cervix following mifepristone or placebo treatment in the first trimester
Albert Szent-Györgyi Medical University, Department of Obstetrics and Gynaecology, H-6725 Szeged, Semmelweis u. 1., Hungary
There is increasing evidence that the antiprogesterone mifepristone (RU-486) can dilate the cervix of pregnant women. The uterine and cervical smooth muscle contractile reponse to adrenergic agonists is regulated by the steroidal environment. This study was undertaken to assess the effects of treatment with RU-486 on the concentrations of alpha- and beta-adrenoceptors in cervical crude membranes from pregnant women using a radioligand binding assay. A special needle biopsy technique was used for human cervical specimens. The probable relative oestrogen dominance due to the antiprogesterone treatment selectively decreased the alpha-2 adrenoceptor in human cervix at an early stage of gestation. This finding was similar to that reported earlier in pregnant rabbits. The existence of a functionally distinct alpha-2 adrenergic receptor subtype will have important implications for our understanding of the contractile activity of the cervix.
Key words: adrenergic receptors/antiprogestogen/cervix
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Wang, Y.-H. Feng, and G. I. Gorodeski Epidermal Growth Factor Facilitates Epinephrine Inhibition of P2X7-Receptor-Mediated Pore Formation and Apoptosis: A Novel Signaling Network Endocrinology, January 1, 2005; 146(1): 164 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Adolfsson, I. Haug, G. Berg, and S. P.S. Svensson Changes in {beta}2-adrenoceptor expression and in adenylyl cyclase and phosphodiesterase activity in human uterine leiomyomas Mol. Hum. Reprod., September 1, 2000; 6(9): 835 - 842. [Abstract] [Full Text] [PDF] |
||||

